Refine by
Nanoparticle Articles & Analysis
98 news found
For more information on CD Bioparticles' custom Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles synthesis services, please visit https://www.cd-bioparticles.com/services/bio-targeted-small-molecules-conjugated-magnetic-nanoparticles.html. About CD Bioparticles CD Bioparticles specializes in manufacturing and supplying nanoparticles, ...
About CD Bioparticles CD Bioparticles specializes in manufacturing and supplying nanoparticles, microparticles, and coatings for diagnostics and research, alongside developing customized, biocompatible drug delivery systems. We offer diverse formulation technologies (from liposomes to polymer nanoparticles) and comprehensive services, including surface ...
The HZ-PEG-HZ (1K) product is critical for applications including: l Controlled Drug Delivery Systems: Leveraging its pH-sensitive hydrazone bonds for targeted and controlled release of active pharmaceutical ingredients in specific physiological environments (e.g., tumor microenvironments, endosomes, lysosomes). l Bioconjugation and Crosslinking: Facilitating the creation of stable linkages in ...
l Oral Thin Films: Fast dissolving method to make patient’s compliance easy by giving easy to use. l Microencapsulation Systems: Guarding actives and allowing for controlled release. l Nanoparticle Development: Solubility enhancement, tissue specificity to get best result from treatment. l Vesicular Systems Engineering: Liposomal and niosomal formulations with enhanced ...
CD Bioparticles provides a range of endotoxin free silver nanoparticles with sizes varying from 10 nm to 100 nm. These high-purity (>99%) nanoparticles exhibit low endotoxin levels. ...
It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...
Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in ...
A wide range of lyophilized flash-release formulation types can be developed by Protheragen-ING, which include: particles, nanoparticles, films, microspheres, and fiber bundles. Moreover, Protheragen-ING’s expert team can design and develop the most appropriate lyophilized flash release formulations based on client's needs and requirements. ...
These non-infectious protein nanoparticles facilitate efficient drug transport, unlocking new possibilities in drug delivery systems. ...
It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...
Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein ...
This strategic move is aimed at addressing the rising global demand for Lipid Nanoparticles (LNPs), which are vital for nucleic acid drug delivery, especially in mRNA-based therapies and vaccines. Lipid Nanoparticles have become a groundbreaking delivery mechanism within the biopharmaceutical sector. ...
By utilizing next-generation technologies such as nanoparticles, in-situ gel, hydrogel, and dendrimer, Ace Therapeutics' drug delivery systems can ensure the right amount of medication is administered at the right time, optimizing treatment outcomes and minimizing side effects. ...
About CD Bioparticles CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. ...
For example, the 113-O12B-Lipid Nanoparticles Targeted to Lymph Nodes (Catalog: CDCLP24-013-L), the specific lipids synthesized, can allow specific lymph node targeting. ...
Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein ...
Nanoformulations involve the use of nanoparticles to deliver drugs to targeted sites in the body, allowing for more precise and effective treatment,” said Marketing Chief of CD formulation. ...
It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...
CD Bioscience has been developing imaging technologies for many years and uses high content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging and other technologies to image cellular structures, cell migration, cell proliferation, pathogen infection mechanisms and protein molecule interactions. ...
It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...